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Abstract 
 
Annona muricata or soursop contains acetogenin which can induce apoptosis in vitro 
and has cytotoxic effect. The study has been done to examine soursop leaves extract’s 
potency in vivo especially to induce apoptosis in 7,12-Dimethylbenz[a]anthracene (DMBA)-
induced Sprague Dawley rats. The induction process was done twice a week for five weeks. 
The soursop leaves extract were given in three dosages, that are 200, 400, and 800 mg/kgBW 
for seventeen days after two weeks DMBA induction. Data analysis showed that Annona 
muricata leaves ethanolic extract could enhance p53 pathway significantly with a dose 
independent manner in DMBA-induced rats. 
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INTRODUCTION 
 
Death caused by cancer showed high 
incidence and is increasing by the year. Primary 
liver cancer is the fifth most common cancer 
worldwide and the third most common cause of 
cancer mortality (Parkin, 2001). According to 
WHO, in 2013 the amount of cancer patients 
increased about seven million cases and 2/3 of 
them lived in developing countries (American 
Cancer Society, 2013). If these cases cannot be 
controlled, there will be 26 million people 
suffering from cancer and 17 million of them 
die of cancer in 2030. Ironically, Union for 
International Cancer Control in 2009 said that 
this incidence will grow faster in poor and 
developing countries (Yayasan Kanker 
Indonesia, 2012).  
In United States, more than 12.000 
death cases per year were related to liver cancer 
(Thuluvath, et al., 2006). Based on Basic 
Health Research (RISKESDAS), cancer 
prevalence in Indonesia was 1.4 per 1,000 
people (NIHRD, 2013). While, liver cancer 
incidence for men is 11:100,000 and 3:100,000 
populations for women and it has become the 
third common cause of cancer for men (Pfizer, 
2013). The incidence level of liver cancer in 
men was three times higher than in women and 
during 2005-2009 the incidence number 
increased to 2.3% per year in men and 1.3% in 
women (American Cancer Society, 2013). 
Up to 80% of 30,640 liver cancer cases 
occurred in United States was hepatocellular 
carcinoma (HCC), originating from 
hepatocytes. Common symptoms include 
abdominal pain and/or swelling, weight loss, 
weakness, loss of appetite, jaundice, and fever. 
Moreover, enlargement of the liver is the most 
common physical sign. Some of liver cancer 
risk factor were alcohol-related cirrhosis, 
possibly nonalcoholic fatty liver disease 
associated with obesity, chronic infections with 
hepatitis B virus (HBV) and hepatitis C virus 
(HCV) (American Cancer Society, 2013). 
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Generally, cancer was treated with 
surgery, chemotherapy, or radiotherapy. 
However, those treatments showed toxic side 
effects in normal tissues and also generate 
resistance in cancer cells (King, 2000; Tyagi, et 
al., 2004). Therefore, the drug development for 
a safe, effective, and selective cancer treatment 
is important to be investigated (Gibbs, 2000). 
The new drug discovery for cancer based on 
natural product is potential to be developed 
(Walaszek, et al., 2004).Previous study showed 
that natural compounds were able to inhibit 
and/or kill cancer cell, showing their potential 
as anticancer agents (Umadevi, et al., 2013). 
One of the potential plants is soursop leaves 
(Annona muricata L.). Annona muricata leaves 
contain acetogenin, essential oil, reticuline, 
loreximine, coclaurine, annomurine, and 
higenamine. Acetogenin group was the 
phytochemical components in Annona muricata  
leaves possessing potential effect as anticancer.  
Annona muricata leaves have seventeen 
acetogenin compounds showing cytotoxic 
effect (Kim, et al., 1998). Bullatacin, one of the 
acetogenin compound,were able to induce 
apoptosis in hepatoma in vitro (Chih, et al., 
2001). Based on several researches above, this 
study aimed to explore Annona muricata leaves 
extract potency to induce apoptosis in 7,12-
dimethylbenz[a]anthracene-induced rats by 
enhancing p53 expression. Therefore, this study 
used experimental animal to in vivo anticancer 
study. 
 
MATERIALS AND METHODS 
Location 
 This study was conducted in the 
Pharmacy and Experimental Animal 
Laboratories, Biomedical and Basic Health 
Technology, National Institute of Health 
Research and Development, Ministry of Health. 
 
Extraction  
 Annona muricata leaves were collected 
from South Tangerang and were determined in 
Indonesian Institute of Science. Fresh leaves of 
Annona muricata (6 kg) were dried and ground 
to a coarse powder (1.36 kg), followed by 
maceration with 16 L 96% ethanol (Merck) at 
room temperature for 3 days, stirred every day 
for five minutes. The ethanolic extract was 
filtered and concentrated by rotary evaporator, 
yielding 105.30 g concentrated extract. 
 
Animals 
 A total of 30 female Sprague Dawley rats 
(40 days old), weighed 30-60 g were taken from 
experimental animal laboratory. The animals 
were kept for at least one week before use and 
the rats were given standard pellet diet and 
water ad libitum.  
 
Experimental Procedure 
 All animals were divided into five 
groups, 6 rats in each group, that are negative 
control (Group 1); DMBA control (Group 2); 
extract dose 200 (Group 3); 400 (Group 4); 800 
mg/kgBW (Group 5). Oral treatment of DMBA 
(Sigma) at dose  20 mg/kgBW were given twice 
a week for five weeks. DMBA was dissolved in 
corn oil and extract was dissolved in 0.5% 
CMC-Na. All groups were not treated for two 
weeks (6
th
-7
th
 week) to wait tumor growth. 
Then, group 3.4, and 5 were administered once 
a day by 200, 400, and 800 mg/kgBW extract 
respectively for 17 days. Body weights were 
recorded weekly throughout the study. After 66 
days experiment, all animals were sacrified by 
ketamine. At necropsy, liver were collected and 
fixed in 10% buffered formalin. 
 
Ethical Clearance 
 This study had ethical clearance from 
ethical committee of National Institute of 
Health Research and Development. 
 
Protein p53 Immunohistochemistry 
Staining 
 The liver was sliced into 3-5 µm tissue 
slices and embedded with paraffin. The organ 
section were washed out with xylene to clear up 
the paraffin and dehydrated with ethanol 
(Merck). The slides were immersed in water for 
one minute. For antigen retrieval, the slides 
were boiled in citrate buffer (pH 6.0) for 15 
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minutes and subsequently cooled for 20 
minutes. The slides were washed in phosphate-
buffered saline (PBS) (pH 7.4), and endogenous 
peroxidase was blocked by 0.3% hydrogen 
peroxide for 15 minutes. After that, the sections 
were incubated at 25ºC with anti-p53/Clone 
PAb 240 for 10 minutes.  
 The slides were washed with PBS and 
then the section were incubated at 25ºC with 
horse radish peroxidase as secondary antibody 
for 10 minutes. Then, the slides were incubated 
for 10 minutes at 25ºC with diaminobenzidine 
(DAB) and counter stained with haematoxylin 
eosin before mounting. 
 
Data Analysis 
 The data was analyzed quatitatively by 
cell  color  observation.  The  observation   was  
done as 10 fields of view. The positive 
expression of p53 showed brown color in cell 
cytoplasm. The negative expression showed by 
the absence of brown color in cell cytoplasm. 
 
RESULTS AND DISCUSSION 
 
Apoptosis or programmed cell death is 
needed for the maintenance of cell homeostasis 
and to destroy cells that represent a threat to the 
integrity of organism. Protein p53 is a protein 
that play important role on apoptosis 
mechanism. Indeed, its absence has disastrous 
effects, such as genomic instability, deregulated 
metabolism of reactive oxygen species, 
unleashed acute inﬂammation, cancer, 
developmental malformations. In cancer 
treatment, idea of trying to turn p53 “on” is 
solidly based on the factthat p53 deﬁciency is a 
bad prognostic factorin cancer. Inactivation of 
p53 some cell types are prone to a 
predominantly apoptotic response almost 
regardless of the severity of DNA damage or 
growth arrest (Gudkov and Kamarova, 2010). 
In contrast, casein associates with p53 
on the promoters of several proapoptotic genes 
within chromatin and activates methylation 
within the transcribed regions of the genes. This 
increases their transcription and promotes 
apoptosis (Das, et al., 2007; Tanaka, et al., 
2007). p53 is inactivated (directly or indirectly) 
in the vast majority of human tumors (Soussi, et 
al., 2000), and loss of p53 in tumors is 
associated with an unfavorable prognosis in 
many forms of cancer.  
This has led the p53 ﬁeld to 
predominantly focus on the possibility of 
restoring  p53  activity  as  a  way  to  induce 
cancer cell death (Midgley, et al., 2000; Bykov, 
et al., 2002; Issaeva, et al., 2004; Vassilev, et 
al., 2004). In this study we would like to figure 
out the inhibition of carcinogenesis is by 
observing the expression of apoptotic protein. 
Protein p53 is a multifunctional protein 
regulating cell division and activating 
apoptosis. In this study, we used anti-p53 
staining to observe cytoplasmic color intensity, 
because the anti-p53 was expressed in 
cytoplasmic cell, while p53 expression happens 
in nuclear cell (Looi, et al., 2008; Halasova, et 
al., 2009). 
Immunohistochemistry staining resulted 
brown-stained in the cytoplasm of liver cells 
were classified as positive regardless of staining 
intensity. High intensity of brown area showed 
high expression of anti-p53. Fig. 1 showed that 
DMBA control group highly expressed anti-p53 
and the expression of anti-p53 decrease 
gradually in extract-treated groups (group 3-5). 
Group 5 showed anti-p53 expression like group 
1. Therefore, the apoptosis mechanism might 
occur via p53-dependent pathways. We should 
explore another mechanism of anticancer of 
Annona muricata leaves ethanolic extract. This 
data strengthen in vitro assay revealing Annona 
muricata leaves ethanolic extract mechanism to 
inhibit cancer progression by enhancing 
apoptosis (Chih, et al., 2001). In conclusion, 
Annona muricata leaves ethanolic extract was 
potential to be developed as anticancer agent. 
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Figure 1. fugAnnona muricata leaves extract decreased anti-p53 expression in liver cells in 7,12-
dimethylbenz[a]anthracene-induced rats.(A) Negative control group (Group 1), (B) DMBA 
control group (Group 2), (C) Extract dose 200 mg/kgBW group (Group 3), (D) Extract dose 400 
mg/kgBW group (Group 4), and (E) Extract dose 800 mg/kgBW group (Group 5).  
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